Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 23, 1993 - Issue 11
96
Views
26
CrossRef citations to date
0
Altmetric
Research Article

The disposition and metabolic fate of 14C-meropenem in man

, , , &
Pages 1311-1323 | Received 24 Mar 1993, Accepted 06 Jul 1993, Published online: 22 Sep 2008
 

Abstract

1. The metabolism and pharmacokinetics of 14C-meropenem were studied in five volunteers who received 0-5 g (40 μCi) of the radiolabelled drug by i.v. infusion.

2. The maximum concentration of drug in plasma was 27 ± 2μg/ml (70 μM) corresponding to 98% of plasma radioactivity at the end of a 30 min infusion. The elimination half-life for meropenem in plasma was 1 h and meropenem remained the major radioactive component up to 6 h, but represented a decreasing proportion of the plasma radioactivity with time. One metabolite (the ring-open lactam) accounted for most of the remaining plasma radioactivity. The maximum concentration of metabolite was 1 ± 0.1 μg/ml and the concentration of total radioactivity decreased to 2% of the peak value by 8 h.

3. Over the 5 days of the study, urinary excretion of radioactivity accounted for 99 ± 0.5% dose, most of which was recovered in the first 8 h. There was negligible excretion in faeces.

4. Structural confirmation of the drug-related components in urine was accomplished by h.p.l.c.-mass spectrometry. Meropenem accounted for 71 ± 2% dose of 14C and the ring-open lactam metabolite for most of the remainder, no other metabolites were detected.

5. Meropenem was the major radioactive component in urine up to 8 h after dosing and is therefore remarkably stable to human renal dehydropeptidase (DHP-1) compared with other carbapenems in clinical use.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.